No Data
Guangfa Zhong Zheng refers to Medicine and Health ETF: strengthen the way of Medical Innovation and explore the way of Rapid growth
The current situation of China's aging population and the surge in the demand for chronic disease management have promoted the continuous expansion of China's medical demand in the future. However, in terms of innovative drugs and innovative devices, there is still a big gap between China and the international leading level in previous years. Therefore, since 2017, China has launched health care reform policies one after another to promote pharmaceutical equipment research and development, while increasing investment in research and development. In medical beauty, stomatology, ophthalmology and other medical consumption industries, the scale of the industry is increasing rapidly, and the growth certainty is strong. The aging of the population is increasing, the management of chronic diseases is surging, and the demand for medical care continues to magnify: the proportion of people aged 65 and above, from 200
Beishui sold the Xiaomi Group and increased Geely Automobile's inventory by nearly HK$1.4 billion; Nanshui sold Gree Electric for over 700 million yuan
Southbound Capital made net sales of HK$100 million today, ending 4 consecutive days of net purchases; the Hong Kong Stock Exchange and Pharmaceutical Biotech received net sales of HK$594 million and HK$530 million respectively. Northbound Capital made a small net sale of 177 million yuan, and Gree Electric's net sales reached a record high of nearly eight months; Kweichow Moutai received net sales for 11 consecutive days, with net sales of 517 million yuan today.
US stock outlook | There is still room for growth! Credit Suisse: The S&P 500 Index is expected to reach 5,000 points next year
Allianz: Suggests holding technology stocks; Goldman Sachs boldly predicts workforce recovery! The US unemployment rate is expected to be the lowest in 50 years in 2022; domestic deliveries of Tesla's domestic cars fell 69% month-on-month in July, and exports increased 385% month-on-month; Manbang's Q2 revenue increased by more than 100%.
Beishui once again invested heavily in Tencent and Meituan; Nanshui made net purchases for 2 consecutive days, and “Machinery Mao” Sany Heavy Industries received a net purchase of over 500 million yuan
Southbound Capital made net purchases of HK$5.484 billion today, while Tencent, Meituan, and China Resources Beer received net purchases of HK$3.184 billion, HK$1,857 million, and HK$376 million respectively. Northbound Capital made net purchases of 1,042 million yuan throughout the day and net purchases for 2 consecutive days. Zhayi Innovation and Vail shares received net purchases of 348 million yuan and 266 million yuan respectively.
Selected Hong Kong Stock Announcements | Ideal Automobile-W's sale price is set at HK$118 per share; Geely's total sales in the first 7 months increased 15% year-on-year
Guangzhou Automobile Group sold 1805,500 vehicles in July, with Aian exceeding 105,000 vehicles; Shimao Group's cumulative contract sales in the first 7 months were 174.88 billion yuan, up 25% from the previous year; the medium-term consolidated net profit of Xincheng Development increased by at least 40%; and Chuangmengtiandi received an increase of 11.015 million shares from J.P. Morgan.
Beishui added a large amount of money to Tencent to 5.1 billion, and SMIC to over HK$1.4 billion! Nanshui sold Maotai for 7 consecutive days
Southbound Capital made a net purchase of HK$6.186 billion today. The top three stocks sold were Anta Sports, Li Ning, and Fosun Pharmaceuticals, which received net sales of HK$655 million, HK$583 million, and HK$136 million respectively; Northbound Capital had net sales of 474 million yuan today, and Yiwei Lithium Energy, Tongwei Co., Ltd. and Sany Heavy Industries ranked in the top three in net purchases.